Palla Pharma Limited is an Australia-based vertically integrated pharmaceutical company. The Company's primary activities include production and distribution of Narcotic Raw Material (NRM), Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF) for supply to international pharmaceutical markets, and the production and distribution of poppy seed for supply to international culinary markets. The Company operates through two segments: Australia and Norway. Australia segment activities include Narcotic Raw Material and Poppy Seed production and distribution. Norway segment activities include Active Pharmaceutical Ingredient and Finished Dosage production and distribution. The Company has developed a water-based extraction technology, which is used in NRM production. It operates in Victoria and Tasmania; and northern hemisphere operations based in Norway. It sources its raw materials from Australian poppy growers in Tasmania, New South Wales, and Victoria.
PALA PHAR